The COPD Therapeutics Market was valued at US$ 11,668.8 million in 2022 and is anticipated to reach US$ 20,127.7 million by 2032, growing at a CAGR of 5.1% during the projected period. Chronic Obstructive Pulmonary Disease is a broad term used for defining progressive lung diseases like emphysema, refractory asthma, chronic bronchitis and some other …
Continue reading “COPD Therapeutics Market is Anticipated to Register 5.1% CAGR through 2022-2032”